Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Agilent Technologies Inc
EIR
•Agilent Technologies Inc•August 2, 2019

Agilent Technologies Inc – FDA EIR, Aug 2, 2019

Record Details

An FDA inspection of Agilent Technologies Inc. in Boulder, CO, took place from July 29 to August 2, 2019. This inspection included Good Manufacturing Practice (GMP) surveillance for Active Pharmaceutical Ingredient (API) manufacturing and a Pre-Approval Inspection under Compliance Program 7346.832. The inspection concluded with an FDA Form 483 listing three observations.

The main issues identified concerned the company's laboratory operations. Specifically, laboratory investigations for nonconformances and aberrant data were found to be incomplete and did not consistently identify root causes. The procedure (QC-SOP-6001.23) for such investigations was deemed inadequate, permitting retesting without thoroughly addressing the underlying issues to prevent recurrence. Additionally, procedures intended to prevent objectionable microorganisms in non-sterile API drug substances were not adhered to; inadequate testing prior to incubation was observed, which could inhibit microorganism detection.

Management, including Vice President and General Manager Mr. Brian S. Carothers, acknowledged the FDA Form 483 and committed to submitting an electronic response addressing each observation to the FDA Denver District office. The consequences of non-compliance with GMPs, such as warning letters, product seizure, and operational injunctions, were discussed. As voluntary corrective actions, Agilent Technologies Inc. provided training for QC microbiologists and stated intentions to revise relevant procedures for detailed instructions.

Company
Agilent Technologies Inc
Inspection date
August 2, 2019
Product type
drugs
Office
Center for Drug Evaluation and Research
Person
  • Erika V. Butler (Compliance Officer / Investigator)
View Company Profile

ID · d1aa85e6-6bdc-43d3-8490-e6a8f66dbf35

Other documents for Agilent Technologies Inc
  • 483 - 2019-08-02August 2, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Agilent Technologies Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.